Effects of prostaglandin analogues on aqueous humor outflow pathways

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Nelson S Winkler, Michael P Fautsch

Abstract

Elevated intraocular pressure (IOP) is the most prevalent risk factor for glaucoma. All treatments, whether surgical or pharmaceutical, are aimed at lowering IOP. Prostaglandin analogues are a first line therapy for glaucoma due to their ability to reduce IOP, once-daily dosing, efficacy, and minimal side-effect profile. Whereas prostaglandin analogues have been known to alter aqueous humor outflow through the unconventional (uveoscleral) pathway, more recent evidence suggests their action also occurs through the conventional (trabecular) pathway. Understanding how prostaglandin analogues successfully lower IOP is important, as this information may lead to the discovery of new molecular targets for future therapeutic intervention. This review explores the current understanding of prostaglandin analogue biology as it pertains to IOP reduction and improved aqueous humor outflow facility.

References

Jan 15, 1988·American Journal of Ophthalmology·J R KerstetterL J Kullerstrand
Jun 1, 1996·The British Journal of Ophthalmology·T Matsuo, N Matsuo
Apr 28, 1999·American Journal of Ophthalmology·C B TorisC B Camras
Jul 17, 1999·Drugs & Aging·C Lindén, A Alm
Jul 27, 1999·The Journal of Biological Chemistry·H Nagase, J F Woessner
Aug 27, 1999·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·T L Davis, N A Sharif
Jun 10, 2000·Current Opinion in Ophthalmology·U SchachtschabelR N Weinreb
Jun 15, 2000·Journal of Human Hypertension·J A Colina-ChourioR M Avila-Hernández
Jul 4, 2001·Survey of Ophthalmology·R F Brubaker
Sep 27, 2001·Advances in Therapy·S GandolfiUNKNOWN Bimatoprost Study Group 3
Jun 20, 2002·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ciro CostagliolaLeonardo Mastropasqua
Sep 3, 2002·Survey of Ophthalmology·Lill-Inger LarssonLuca Rossetti
Sep 18, 2002·Journal of Cell Science·Andrew H BakerGillian Murphy
Jan 24, 2003·Critical Reviews in Biochemistry and Molecular Biology·Philippe E Van den SteenGhislain Opdenakker
Mar 27, 2003·Investigative Ophthalmology & Visual Science·John H K LiuRobert N Weinreb
Apr 26, 2003·Investigative Ophthalmology & Visual Science·Xiujun ZhaoPaul Russell
Jul 11, 2003·Survey of Ophthalmology·Richard F Brubaker
Jul 29, 2003·Investigative Ophthalmology & Visual Science·Iok-Hou PangAbbot F Clark
Sep 18, 2003·Ophthalmology·Dan Eisenberg
Jan 22, 2004·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·N A SharifS X Xu
Apr 17, 2004·International Ophthalmology Clinics·Quang H Nguyen
Apr 28, 2004·The International Journal of Biochemistry & Cell Biology·Carina L BosHenri H Versteeg
Sep 17, 2004·Pharmacology & Therapeutics·Aaron N Hata, Richard M Breyer
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jae B Park
Aug 4, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Burkhard HinzKay Brune
Oct 27, 2005·Investigative Ophthalmology & Visual Science·Takashi OtaMakoto Araie
Nov 26, 2005·Current Medical Research and Opinion·Stefan HolmstromMark Aagren
Jan 13, 2006·Cardiovascular Research·Hideaki NagaseGillian Murphy

❮ Previous
Next ❯

Citations

Oct 19, 2016·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jonathan S MyersRudolf A Baumgartner
Feb 26, 2016·Advances in Therapy·Anastasios G P KonstasStefano Miglior
Jan 20, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Najam A Sharif
Jul 2, 2016·Journal of Medicinal Chemistry·Uttio Roy ChowdhuryPeter I Dosa
Aug 23, 2016·Expert Opinion on Investigational Drugs·Jed Asher Lusthaus, Ivan Goldberg
Feb 9, 2016·Expert Opinion on Emerging Drugs·Jed Asher Lusthaus, Ivan Goldberg
Aug 8, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Megan E Cavet, Heleen H DeCory
Apr 19, 2018·British Journal of Pharmacology·Francesco ImpagnatielloMichael V W Bergamini
Sep 20, 2018·Expert Opinion on Investigational Drugs·Artemis Matsou, Eleftherios Anastasopoulos
Feb 16, 2019·The Medical Journal of Australia·Jed Lusthaus, Ivan Goldberg
Oct 28, 2019·International Journal of Molecular Sciences·Hong Ryul AhnSang Hoon Jung
Jul 1, 2020·Micromachines·Renhao LuEsak Lee
May 27, 2020·Investigative Ophthalmology & Visual Science·Jessica Y ChenJoseph L Demer
Jul 28, 2020·Expert Opinion on Pharmacotherapy·Wesam Shamseldin ShalabyL Jay Katz
Aug 28, 2020·Investigative Ophthalmology & Visual Science·Ester Reina-TorresDarryl R Overby
Nov 27, 2020·The British Journal of Ophthalmology·Jacques A BertrandDarryl R Overby
Jan 28, 2021·European Journal of Ophthalmology·Ahmed Essam FaseehMai Nasser Abd Elmohsen
Oct 18, 2019·Survey of Ophthalmology·Ciro CostagliolaLeonardo Mastropasqua
Mar 11, 2021·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Henrietta WangJack Phu
Mar 25, 2021·Current Eye Research·Gavin W RoddyMichael P Fautsch
Aug 19, 2021·Translational Vision Science & Technology·Eric MikulaTibor Juhasz
Aug 17, 2021·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Janelle TongBarbara Zangerl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Investigative Ophthalmology & Visual Science
B'Ann True GabeltPaul L Kaufman
Current Molecular Medicine
Carol B Toris
Investigative Ophthalmology & Visual Science
Arthur J SitDavid O Hodge
Current Opinion in Ophthalmology
Camille Hylton, Alan L Robin
© 2021 Meta ULC. All rights reserved